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Background
During exercise, the demand for oxygen and energy sub-
strates is elevated in active skeletal muscle. Supplements
with high nitrate and polyphenol content have been
shown to increase nitric oxide production and enhance
exercise efficiency. The current randomized, double-blind,
placebo-controlled, crossover study aimed to investigate
the acute effects of pomegranate extract on blood flow,
vessel diameter, and exercise performance in active
individuals.
Methods
Nineteen men and women (Mean ± SD; Age: 22.2 ±
2.2 yrs; Height: 174.8 ± 10.7 cm; Body mass: 71.9 ±
13.5 kg) performed a graded exercise treadmill test to
volitional exhaustion to determine maximal oxygen
consumption and peak velocity (PV). Treatment order
was randomly assigned. Participants returned after
24-48 hours, and ingested two, 500mg capsules of either
placebo (PL; 95% maltodextrin, 5% purple carrot and
hibiscus for color) or pomegranate extract (PE; 1000 mg,
TRUE Pomegranate Extract [NITRO2GRANIT
™], Stiebs
Nature Elevated, Madera, CA) with 6 oz. of water. Brachial
artery blood flow was assessed using a GE logiq-e B-mode
ultrasound (GE Healthcare, Wisconsin, USA) at baseline
and 30 minutes post ingestion (30PI). In random order,
subjects performed three treadmill runs to exhaustion at
90%, 100%, and 110%PV to determine critical velocity
(CV), anaerobic running capacity (ARC), and time to
exhaustion (TTE). Blood flow was assessed immediately
after and 30 minutes after each exercise bout. A vitality
scale was completed 30PI of PE or PL; a visual analog
(pain) scale (VAS) was completed 30PI and immedia-
tely post exercise. After a 7-10 day washout period,
participants repeated the same procedures, ingesting the
opposite supplement. Separate mixed factorial ANOVAs
were performed for blood flow, vessel diameter, CV,
ARC, TTE, VAS, and vitality scale questions. Consent to
publish the results was obtained from all participants.
Results
Blood flow was significantly augmented 30PI of PE in
comparison to PL (p=0.033). Vessel diameter was signifi-
cantly larger following 30 minutes post exercise with PE
(p=0.036). Ingestion of the PE was found to significan-
tly augment TTE at 90%PV (p=0.009) and 100% PV
(p=0.027). On the vitality scale, the following statement,
“At this moment I feel alive and vital” was found to be sig-
nificantly greater 30PI of PE compared to PL (p=0.037).
Conclusions
Acute ingestion of PE 30 minutes prior to exercise may
enhance vessel diameter, blood flow, and improve exercise
tolerance. Results of the current study indicate that PE is
an ergogenic aid for submaximal running, eliciting benefi-
cial effects on blood flow.
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